Security key
78397T202
SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)
CUSIP: 78397T202
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 458,365
- Total 13F value
- $1,452,833
- Share change
- -12,544
- SEC-reported price per share
- $3.17
- Number of holders
- 8
- Value change
- -$39,763
- Number of buys
- 5
- Number of sells
- 1
- Shares outstanding
- 226,597,678
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
8
Top holders
8
SABS full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
SAB Biotherapeutics, Inc. SEC filings
SAB Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78397T202
Recent filing periods:
Ownership snapshot
Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
11/15
Latest evidence
06 Aug 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
4 rows are not safely comparable across share classes.
13D/G row: Vivo Opportunity Fund Holdings, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership
Top 5
Vivo Opportunity Fund Holdings, L.P.
10%
RA CAPITAL MANAGEMENT, L.P.
9.9%
Commodore Capital LP
9.9%
BALYASNY ASSET MANAGEMENT L.P.
9.4%
BIOTECHNOLOGY VALUE FUND L P
9.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
10%
Reported 13D/G
· 30 Jun 2026
|
$89,642,948
22,637,108 shares
|
-$13,043,812 | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
9.9%
Reported 13D/G
· 06 Aug 2026
|
$38,055,014
9,609,852 shares
|
+$9,102,563 | 06 Aug 2026 |
| Commodore Capital LP |
13D/G
13F
Company
|
9.9%
Reported 13D/G
· 30 Jun 2026
|
$35,434,753
8,948,170 shares
|
+$17,523,764 | 30 Jun 2026 |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
13F
Company
|
9.4%
Reported 13D/G
· 30 Jun 2026
|
$28,612,738
7,225,439 shares
|
+$8,456,580 | 30 Jun 2026 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
9.1%
Reported 13D/G
· 31 Dec 2025
|
$18,761,910
4,761,906 shares
|
-$1,598,505 | 31 Dec 2025 |
| Caligan Partners LP |
13D/G
13F
Company
|
8.8%
Reported 13D/G
· 30 Jun 2026
|
$31,550,140
7,967,207 shares
|
$0 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
458,365
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q4 2025 Across Filers
Q4 2025 holders
48
Q3 2026 holders
8
Holder diff
-40
| Investor | Q4 2025 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend